Durham, N.C.
Merck is building a $100 million, 110,000-sf pharmaceutical production facility in the Treyburn Corporate Park in Durham, N.C. Comprised of quality testing labs, a sterile processing plant, and packaging, the project is slated for completion in 2010 and represents the second phase of expansion at Merck’s vaccine manufacturing complex. The first $300 million, 235,000-sf phase was completed in spring of 2008. The third phase, a $300 million manufacturing, warehouse, and administrative facility, will reach completion in 2011.
